Low-Thoracic Epidural Anesthesia For Laparoscopic Nephrectomy.
Launched by NAZMY EDWARD SEIF · Sep 6, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a specific type of anesthesia called epidural anesthesia for patients undergoing laparoscopic nephrectomy, which is a minimally invasive surgery to remove a kidney. The goal is to see how epidural anesthesia compares to the usual general anesthesia in terms of patient comfort and safety during the surgery. Researchers believe that using epidural anesthesia might lead to less pain after surgery and fewer complications, especially for older or higher-risk patients.
To participate in this trial, you would need to be an adult scheduled for laparoscopic nephrectomy and classified as having a low to moderate risk for anesthesia (ASA I-II). However, if you have certain medical conditions that prevent the use of regional anesthesia, or if you are allergic to local anesthetics, you wouldn’t be eligible. If you join the study, you can expect to receive either the epidural anesthesia or the standard general anesthesia during your surgery, and the research team will monitor your recovery to compare the outcomes. This trial is currently looking for participants, so if you're interested, it's a good idea to discuss it with your doctor.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I - II.
- • Adult patients scheduled for laparoscopic nephrectomy.
- Exclusion Criteria:
- • Patient refusal.
- • Contraindication to regional anesthesia (e.g., coagulopathy, site infection).
- • Allergy to local anesthetics.
About Nazmy Edward Seif
Nazmy Edward Seif is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic solutions, the organization collaborates with leading healthcare professionals and institutions to design and execute rigorous clinical studies. Emphasizing patient safety and ethical standards, Nazmy Edward Seif strives to facilitate the seamless transition of groundbreaking therapies from the laboratory to clinical practice, ultimately aiming to improve patient outcomes and enhance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Nazmy S Michael, MD
Principal Investigator
Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University
Atef K Salama, MD
Study Director
Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials